Nicholas J Leeper

31PUBLICATIONS
168CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Environmental biogeochemistryPharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jun 05, 2026
Multimodal atlas of human atherosclerosis links granular vascular cell states to coronary artery disease risk.

|Apr 07, 2026
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial.

Gerald F Watts, Russell Scott, David Sullivan

|Mar 02, 2026
Microplastics and Nanoplastics: A New Perspective in Cardiovascular Prevention.

Kai-Uwe Jarr, Annette Peters, Nicholas J Leeper

|Feb 24, 2026
From biobank to prediction: polygenic risk scores for peripheral artery disease.

Eri Fukaya, Nicholas J Leeper

|Oct 15, 2025
Genetic modelling of triglyceride-rich lipoprotein/remnant lowering mimics APOC3-silencing and predicts clinically relevant coronary heart disease event reductions.

Elias Björnson, Chris Packard, Martin Adiels

|Sep 09, 2025
The atherosclerosis-cancer axis: the shared immunotherapeutic potential of CBL inhibition.

Kai-Uwe Jarr, Lingfeng Luo, Nicholas J Leeper

Pageof 6

Frequent Collaborators

6 joint publications

Kai-Uwe Jarr

5 joint publications

Clint L Miller

5 joint publications

Lingfeng Luo

4 joint publications

Gerard Pasterkamp